查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829845

2025年全球荷尔蒙子宫内避孕器（IUD）市场报告

Hormonal Intrauterine Devices (IUDs) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，荷尔蒙子宫内避孕器 (IUD) 市场快速扩张，从 2024 年的 26.1 亿美元成长至 2025 年的 28.7 亿美元，复合年增长率达 10.2%。这一历史性增长可归因于更安全、更有效的荷尔蒙製剂的开发、对长期避孕解决方案的需求不断增长、医疗保健提供者的推荐增加、公众对避孕选择的认识不断提高，以及医疗技术和器械设计的进步。

预计未来几年荷尔蒙子宫内避孕器 (IUD) 市场将快速成长，到 2029 年将达到 42.9 亿美元，复合年增长率为 10.6%。预测期内成长的主要驱动因素包括：人们对避孕选择的认识不断提高、对长效可逆避孕的偏好日益增长、设备安全性和有效性的进步、对个人化医疗保健的日益重视以及医疗保健提供者的广泛普及。预测期内的主要趋势包括：设备技术的进步、避孕选择的个人化程度不断提高、以患者为中心的医疗保健方法的兴起、对永续和环保产品的需求不断增长以及新型避孕产品的开发。

子宫内避孕器（IUD）是一种小型的T形塑胶装置，可置入子宫并释放合成的黄体素。这些装置透过增稠子宫颈黏液来阻断精子，使子宫内膜变薄以防止着床，有时还能抑制排卵，从而达到避孕的目的。它们还可以减少月经出血和经痛，在某些情况下甚至可以完全停止月经。

荷尔蒙子宫内避孕器的主要类型包括13毫克、19毫克和52毫克。 13毫克的激素子宫内避孕器可释放低剂量激素，最长可达三年，在寻求长效避孕且激素暴露较少的女性中越来越受欢迎。这类节育器设计多样，包括有框和无框子宫内避孕器，并包含不同的荷尔蒙类型，例如释放levonorgestrel和释放孕酮的子宫内避孕器。这些选择适合不同年龄段，包括20-24岁、25-34岁和35-44岁。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供了您在激素宫内节育器 (IUD) 行业取得成功所需的所有数据，涵盖激素宫内节育器 (IUD) 市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的激素宫内节育器 (IUD) 细分市场、市场份额和详细的激素宫内节育器 (IUD) 市场、市场份额和详细的激素宫内节育器 (IUD) 市场、市场份额和详细的激素宫内节育器 (IUD) 市场。本激素子宫内避孕器 (IUD) 市场研究报告透过对产业现状和未来情况的详细分析，为您提供完整的展望。

未来五年预测成长率为10.6%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自芬兰和瑞士等主要地区的levonorgestrel缓释储药器和T型聚合物框架征收关税直接影响美国，并可能导致避孕选择减少和长期避孕成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响可能会更加广泛。

意外怀孕发生率的上升预计将推动荷尔蒙避孕器器市场的未来成长。意外妊娠是指在受孕时未计划或不想要的妊娠，原因可能多种多样，包括避孕失败、缺乏避孕途径、避孕不当以及性暴力。有效避孕途径的匮乏降低了个人对生育选择的自主权，并增加了意外怀孕的可能性。荷尔蒙子宫内避孕器在避孕方面非常有效，失败率低于1%。它们能够提供长期保护（根据类型，保护期为3-7年），是希望避免意外妊娠人士的可靠选择。例如，2023年8月，英国卫生和社会保障部下属政府机构健康改善与不平等办公室报告称，2022年1月至6月期间，英格兰和威尔斯居民共进行了123,219次堕胎，与2021年同期相比增加了17%。因此，意外怀孕的增加正在促进荷尔蒙子宫内避孕器市场的成长。

荷尔蒙子宫内避孕器市场的主要参与者正致力于开发先进产品，例如levonorgestrel子宫内释放系统，为女性提供更个人化的避孕解决方案。levonorgestrel子宫内释放系统 (LNG-IUS) 是一种荷尔蒙子宫内避孕器，可在子宫内稳定释放合成levonorgestrel。这种荷尔蒙会使子宫颈黏液变稠，改变子宫内膜，并阻止精子到达卵子。例如，2022 年 11 月，致力于改善女性获得基本药物和保健产品的美国製药组织 Medicines360 推出了 FDA核准的LILETTA。 Liletta 是美国现有持续时间最长的荷尔蒙子宫内避孕器之一，核准用于避孕长达八年，用于治疗月经过多长达五年。这种子宫内避孕器在广泛人群中避孕的有效率约为 99%。它配备符合人体工学的插入器，方便医生在咨询时轻鬆插入，并可随时取出。 Liletta 以处方笺购买，并透过 340B 药品定价计划以折扣价出售，这与 Medicines360 提升女性医疗保健可及性的使命相一致。

2024年1月，Medicines360与DKT WomanCare Global合作。 DKT WomanCare Global是一家总部位于法国的公司，专注于女性性与生殖健康产品的可近性、可近性和可及性。此次策略合作旨在提高人们对Avibela（一款价格实惠的荷尔蒙子宫内避孕器）的认知度，并扩大市场覆盖范围，尤其是在医疗资源匮乏的地区，从而提高产品的可及性和可及性，改善全球性与生殖健康。

荷尔蒙子宫内避孕器 (IUD) 市场包括荷尔蒙储存器、线绳以及置入和取出装置的销售。此市场的价值是指“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球荷尔蒙子宫内避孕器 (IUD)：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球荷尔蒙子宫内避孕器（IUD）市场：成长率分析
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场表现：规模与成长，2019-2024 年
  • 全球子宫内避孕器 (IUD) 市场预测：2024-2029 年及 2034 年规模与成长
  • 全球荷尔蒙子宫内避孕器（IUD）：总目标市场（TAM）

第六章 市场细分

  • 全球荷尔蒙子宫内避孕器 (IUD) 市场类型、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 13毫克激素子宫内避孕器
  • 19毫克激素子宫内避孕器
  • 52毫克激素子宫内避孕器
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场（按装置设计、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
  • 框架式子宫内避孕器
  • 无框架子宫内避孕器
  • 全球子宫内避孕器 (IUD) 市场（依荷尔蒙类型、实际规模及预测），2019-2024 年、2024-2029 年、2034 年
  • levonorgestrel子宫内避孕器
  • 释放孕酮的子宫内避孕器
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场：按应用、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 20-24岁
  • 25-34岁
  • 35至44岁
  • 其他用途
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场：按 13 毫克激素子宫内避孕器 (IUD) 类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 低剂量13毫克子宫内避孕器
  • 针对特定情况的专用 13mg 子宫内避孕器
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场：19 毫克激素子宫内避孕器细分市场（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 低剂量19毫克子宫内避孕器
  • 针对特定情况的专用 19mg 子宫内避孕器
  • 全球荷尔蒙子宫内避孕器 (IUD) 市场：按 52 毫克激素子宫内避孕器 (IUD) 类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 标准 52mg 子宫内避孕器
  • 缓释性52mg 子宫内避孕器
  • 52毫克子宫内避孕器推荐用于治疗月经过多和子宫内膜异位症

第七章 区域和国家分析

  • 全球子宫内避孕器 (IUD) 市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球子宫内避孕器 (IUD) 市场：国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 子宫内避孕器（IUD）市场：竞争格局
  • 子宫内避孕器（IUD）市场：公司简介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Meril Life Science Pvt Ltd.
  • Bharat Serums and Vaccines Limited
  • Teva UK Limited
  • EurimPharm
  • HRA Pharma SAS
  • Medicines360
  • Hll Lifecare Limited
  • Pregna International Ltd.
  • Allergan plc
  • Actavis Inc.
  • DKT WomanCare Global
  • CrossBay Medical Inc.
  • SMB Corporation of India
  • Oy Leiras
  • OCON Healthcare

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年子宫内避孕器（IUD）市场：哪些国家将提供新机会
  • 2029年子宫内避孕器（IUD）市场：细分市场带来新机会
  • 2029年子宫内避孕器（IUD）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31957u

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hormonal intrauterine devices (IUDs) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (IUDs) market statistics, including hormonal intrauterine devices (IUDs) industry global market size, regional shares, competitors with a hormonal intrauterine devices (IUDs) market share, detailed hormonal intrauterine devices (IUDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (IUDs) industry. This hormonal intrauterine device (IUDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.61 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the development of safer and more effective hormonal formulations, rising demand for long-term birth control solutions, increasing healthcare provider recommendations, greater public awareness of contraceptive options, and advancements in medical technology and device design.

The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising awareness of contraceptive choices, increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, growing emphasis on personalized healthcare, and broader availability through healthcare providers. Major trends in the forecast period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, development of new contraceptive products.

The forecast of 10.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on levonorgestrel-eluting reservoirs and T-shaped polymer frames, sourced from key regions such as Finland and Switzerland, which could lead to reduced contraceptive options and higher costs for long-term birth control methods.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of unwanted pregnancies is projected to drive the growth of the hormonal intrauterine devices market in the future. Unwanted pregnancies refer to those that are not planned or desired at the time of conception and can arise from various factors, such as contraceptive failure, lack of access to birth control, improper use of contraception, or sexual violence. Limited access to effective contraceptive methods diminishes individuals' control over their reproductive choices, increasing the likelihood of unwanted pregnancies. Hormonal IUDs are highly effective in preventing pregnancy, boasting a failure rate of less than 1%. They offer long-term protection (ranging from 3 to 7 years, depending on the specific type) and serve as a reliable option for those looking to avoid unintended pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a UK governmental unit within the Department of Health and Social Care, reported that between January and June 2022, there were 123,219 abortions among residents of England and Wales, representing a 17% increase compared to the same period in 2021. Thus, the rise in unwanted pregnancies is contributing to the growth of the hormonal intrauterine devices market.

Key players in the hormonal intrauterine devices market are focusing on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to offer more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal IUDs that steadily release levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and modifies the uterine lining, preventing sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization dedicated to improving women's access to essential medicines and health products, launched the FDA-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs available in the U.S., approved for contraception for up to 8 years and for treating heavy menstrual bleeding for up to 5 years. It is approximately 99% effective in preventing pregnancy among diverse populations. The device comes with an ergonomic inserter for easy placement during a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced price through the 340B drug pricing program, aligning with Medicines360's mission to enhance access to women's healthcare.

In January 2024, Medicines360 formed a partnership with DKT WomanCare Global, a France-based company focused on the availability, accessibility, and affordability of sexual and reproductive health products for women. This strategic collaboration aims to enhance the availability and accessibility of the affordable hormonal IUD, Avibela, by raising awareness and expanding market reach, particularly in underserved areas, and is intended to improve global sexual and reproductive health.

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (IUDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal intrauterine devices (iuds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (iuds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hormonal intrauterine devices (iuds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
  • 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
  • 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
  • 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
  • Subsegments:
  • 1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs; Specialty 13 Mg IUDs For Specific Conditions
  • 2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs; Specialty 19 Mg IUDs For Specific Conditions
  • 3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs; Extended-Release 52 Mg IUDs; Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Organon & Companies; Gedeon Richter Plc; Meril Life Science Pvt Ltd.; Bharat Serums and Vaccines Limited; Teva UK Limited; EurimPharm; HRA Pharma SAS; Medicines360; Hll Lifecare Limited; Pregna International Ltd.; Allergan plc; Actavis Inc.; DKT WomanCare Global; CrossBay Medical Inc.; SMB Corporation of India; Oy Leiras; OCON Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

3. Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

4. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hormonal Intrauterine Devices (IUDs) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hormonal Intrauterine Devices (IUDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hormonal Intrauterine Devices (IUDs) Market Growth Rate Analysis
  • 5.4. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hormonal Intrauterine Devices (IUDs) Total Addressable Market (TAM)

6. Hormonal Intrauterine Devices (IUDs) Market Segmentation

  • 6.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13 Milligram Hormonal Intrauterine Devices
  • 19 Milligram Hormonal Intrauterine Devices
  • 52 Milligram Hormonal Intrauterine Devices
  • 6.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Framed Intrauterine Devices
  • Frameless Intrauterine Devices
  • 6.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Levonorgestrel Releasing Intrauterine Devices
  • Progesterone Releasing Intrauterine Devices
  • 6.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Other Applications
  • 6.5. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 13 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose 13 Mg IUDs
  • Specialty 13 Mg IUDs For Specific Conditions
  • 6.6. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 19 Milligram Hormonal Intrauterine Devices,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Dose 19 Mg IUDs
  • Specialty 19 Mg IUDs For Specific Conditions
  • 6.7. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 52 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard 52 Mg IUDs
  • Extended-Release 52 Mg IUDs
  • Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

7. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

  • 7.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

  • 8.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormonal Intrauterine Devices (IUDs) Market

  • 9.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
  • 9.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormonal Intrauterine Devices (IUDs) Market

  • 10.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormonal Intrauterine Devices (IUDs) Market

  • 11.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
  • 11.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormonal Intrauterine Devices (IUDs) Market

  • 12.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormonal Intrauterine Devices (IUDs) Market

  • 13.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormonal Intrauterine Devices (IUDs) Market

  • 14.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
  • 14.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormonal Intrauterine Devices (IUDs) Market

  • 15.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 15.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormonal Intrauterine Devices (IUDs) Market

  • 16.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormonal Intrauterine Devices (IUDs) Market

  • 17.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormonal Intrauterine Devices (IUDs) Market

  • 18.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormonal Intrauterine Devices (IUDs) Market

  • 19.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormonal Intrauterine Devices (IUDs) Market

  • 20.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

  • 21.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 21.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormonal Intrauterine Devices (IUDs) Market

  • 22.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormonal Intrauterine Devices (IUDs) Market

  • 23.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 23.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormonal Intrauterine Devices (IUDs) Market

  • 24.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
  • 24.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormonal Intrauterine Devices (IUDs) Market

  • 25.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
  • 25.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormonal Intrauterine Devices (IUDs) Market

  • 26.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 26.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormonal Intrauterine Devices (IUDs) Market

  • 27.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormonal Intrauterine Devices (IUDs) Market

  • 28.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
  • 28.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormonal Intrauterine Devices (IUDs) Market

  • 29.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
  • 29.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

  • 30.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape
  • 30.2. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis

31. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

  • 31.1. Meril Life Science Pvt Ltd.
  • 31.2. Bharat Serums and Vaccines Limited
  • 31.3. Teva UK Limited
  • 31.4. EurimPharm
  • 31.5. HRA Pharma SAS
  • 31.6. Medicines360
  • 31.7. Hll Lifecare Limited
  • 31.8. Pregna International Ltd.
  • 31.9. Allergan plc
  • 31.10. Actavis Inc.
  • 31.11. DKT WomanCare Global
  • 31.12. CrossBay Medical Inc.
  • 31.13. SMB Corporation of India
  • 31.14. Oy Leiras
  • 31.15. OCON Healthcare

32. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

34. Recent Developments In The Hormonal Intrauterine Devices (IUDs) Market

35. Hormonal Intrauterine Devices (IUDs) Market High Potential Countries, Segments and Strategies

  • 35.1 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hormonal Intrauterine Devices (IUDs) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer